Literature DB >> 28647756

Role of coronal high-resolution diffusion-weighted imaging in acute optic neuritis: a comparison with axial orientation.

Ping Lu1,2, Yan Sha3, Hailin Wan2, Feng Wang2, Guohong Tian4.   

Abstract

PURPOSE: Through a comparison with the axial orientation, we aimed to evaluate the role of coronal high-resolution diffusion-weighted imaging (DWI) in acute optic neuritis based on diagnostic accuracy and the reproducibility of apparent diffusion coefficient (ADC) measurements.
METHODS: Orbital DWI, using readout-segmented, parallel imaging, and 2D navigator-based reacquisition (RESOLVE-DWI), was performed on 49 patients with acute vision loss. The coronal (thickness = 3 mm) and axial (thickness = 2 mm) diffusion images were evaluated by two neuroradiologists retrospectively. The sensitivity, specificity, and accuracy were calculated through diagnostic test; the inter- and intra-observer reliabilities were assessed with a weighted Cohen's kappa test. In addition, the agreement of ADC measurement among observers was evaluated by the intra-class correlation coefficient (ICC), coefficient of variation (CV), and Bland-Altman plots. Comparison of ADC values was also performed by unpaired t test.
RESULTS: Among the 49 patients, 47 clinically positive optic nerves and 51 clinically negative optic nerves were found. The sensitivity, specificity, and accuracy were 85.1/87.2%, 90.2/94.12%, and 87.8/90.8%, respectively, for coronal RESOLVE-DWI and 83.0/85.1%, 66.7/76.5%, and 75.5/79.6%, respectively, for axial RESOLVE-DWI. The inter-observer kappa values were 0.710 and 0.806 for axial and coronal RESOLVE-DWI, respectively, and the intra-observer kappa values were 0.822 and 0.909, respectively (each P < 0.0001). Regarding the reproducibility of ADC measurements on axial and coronal RESOLVE-DWI, the ICCs among observers were 0.846 and 0.941, respectively, and the CV values were 7.046 and 4.810%, respectively. Bland-Altman plots revealed smaller inter-observer variability on coronal RESOLVE-DWI. ADC values were significantly lower in positive group (each P < 0.0001).
CONCLUSION: Higher specificity and better reproducibility of ADC measurements were found for coronal RESOLVE-DWI, which demonstrated the feasibility of the use of coronal RESOLVE-DWI to examine acute optic neuritis patients.

Entities:  

Keywords:  Axial; Coronal; ICC; Optic neuritis; Resolve-DWI

Mesh:

Year:  2017        PMID: 28647756     DOI: 10.1007/s00234-017-1853-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  24 in total

Review 1.  Assessment of optic nerve damage in multiple sclerosis using magnetic resonance imaging.

Authors:  J H Simon; W I McDonald
Journal:  J Neurol Sci       Date:  2000-01-15       Impact factor: 3.181

2.  High-resolution human diffusion tensor imaging using 2-D navigated multishot SENSE EPI at 7 T.

Authors:  Ha-Kyu Jeong; John C Gore; Adam W Anderson
Journal:  Magn Reson Med       Date:  2012-05-16       Impact factor: 4.668

3.  Diffusion-weighted MR imaging in posterior ischemic optic neuropathy.

Authors:  Ashish Verma; Krishan K Jain; Suvash Mohan; Rajendra V Phadke
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-28       Impact factor: 3.825

4.  Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.

Authors:  R S Samson; M Kolappan; D L Thomas; M R Symms; P Connick; D H Miller; Claudia A M Wheeler-Kingshott
Journal:  Funct Neurol       Date:  2013 Apr-May

5.  Initial experience of correlating parameters of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T in nasopharyngeal carcinoma.

Authors:  Qian-Jun Jia; Shui-Xing Zhang; Wen-Bo Chen; Long Liang; Zheng-Gen Zhou; Qian-Hui Qiu; Zai-Yi Liu; Qiong-Xin Zeng; Chang-Hong Liang
Journal:  Eur Radiol       Date:  2014-07-23       Impact factor: 5.315

Review 6.  Mimics and chameleons of optic neuritis.

Authors:  Dinushi Weerasinghe; Christian Lueck
Journal:  Pract Neurol       Date:  2016-01-13

7.  Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.

Authors:  Scott Kolbe; Caron Chapman; Thanh Nguyen; Clare Bajraszewski; Leigh Johnston; Michael Kean; Peter Mitchell; Mark Paine; Helmut Butzkueven; Trevor Kilpatrick; Gary Egan
Journal:  Neuroimage       Date:  2009-01-07       Impact factor: 6.556

8.  Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis.

Authors:  Simon J Hickman; Claudia A M Wheeler-Kingshott; Stephen J Jones; Katherine A Miszkiel; Gareth J Barker; Gordon T Plant; David H Miller
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 9.  Diffusion-weighted imaging of the spinal cord and optic nerve.

Authors:  G J Barker
Journal:  J Neurol Sci       Date:  2001-05-01       Impact factor: 3.181

10.  Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy.

Authors:  Kevin H Boegel; Andrew E Tyan; Veena R Iyer; Jeffrey B Rykken; Alexander M McKinney
Journal:  Eur J Radiol Open       Date:  2017-02-28
View more
  3 in total

1.  Comparison of field-of-view optimized and constrained undistorted single-shot diffusion-weighted imaging and conventional diffusion-weighted imaging of optic nerve and chiasma at 3T.

Authors:  Yuan Tian; Junqing Wang; Mingge Li; Xin Lou; Jing Tang; Quangang Xu; Yingkui Zhang; Shihui Wei; Lin Ma
Journal:  Neuroradiology       Date:  2018-07-19       Impact factor: 2.804

2.  Advanced diffusion-weighted imaging in patients with optic neuritis deficit - value of reduced field of view DWI and readout-segmented DWI.

Authors:  Achim Seeger; Maximilian Schulze; Frank Schuettauf; Ulrike Ernemann; Till-Karsten Hauser
Journal:  Neuroradiol J       Date:  2018-02-08

3.  Clinical characteristics of optic neuritis phenotypes in a 3-year follow-up Chinese cohort.

Authors:  Chaoyi Feng; Qian Chen; Guixian Zhao; Zhenxin Li; Weimin Chen; Yan Sha; Xinghuai Sun; Min Wang; Guohong Tian
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.